Cart
0

Asia Pacific IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_171256
Pages: 180
Sep 2017 | 2868 Views
 
Author's : Sharayu Dhabale
Tables: 69
Charts: 54
 

Asia-Pacific IVD Market Overview:

The Asia-Pacific IVD Market accounted for $13,680 million in 2016, and is estimated to reach at $19,888 million by 2023, growing at a CAGR of 5.4% from 2017 to 2023. IVD are the medical diagnostic devices comprised of any reagent, calibrator, control material, kit, specimen receptacle, software, instrument, apparatus, equipment or system; used alone or in combination with other diagnostic devices, specifically designed for in-vitro examination of specimens of human body.

Increase in prevalence of communicable and non-communicable diseases and large pool of geriatric population in Asia-Pacific primarily drives the Asia-Pacific IVD market. In addition, growth in trend toward personalized medicine and use of companion diagnostics devices have increased the IVD market growth. Furthermore, growth in investment in healthcare sector by government is anticipated to boost the market growth. However, stringent government regulations associated with production and sale of IVD are expected to hamper the market growth. Ongoing R&D activities related to IVD are anticipated to present new opportunities for the market. Moreover, the Asia-Pacific region offers lucrative growth opportunities to the Asia-Pacific IVD market players owing to the increase in economies of the countries such as India, South Korea, China, and others.

Asia-Pacific IVD Market Segmentation

Asia-Pacific IVD Market Segmentation

 

Get more information on this report : Request Sample Pages

Segment Review

Based on product type, the market is categorized into reagents, instruments, and software & services. The reagent segment accounted for the highest market share in 2016, and the software and services is expected to grow at the highest growth rate during the forecast period. The growth of the reagent market is attributed to the recent introduction of new novel reagents and wide availability of effective and cost-efficient reagents. On the basis of techniques, the immunodiagnostics segment captured the highest market share in 2016, due to the increase in demand for personalized medicines. On the basis of application, infectious diseases segment captured the highest market share in 2016, owing to the increase in prevalence of infectious diseases and rise in increase in preventive healthcare awareness among the population. Based on end users, the standalone laboratory segment captured the highest market share in 2016, primarily due to non-availability of complex tests in hospitals and commercial clinics.

Top Investment Pocket

Asia-Pacific IVD Market Top Investment Pocket

Get more information on this report : Request Sample Pages

Country Wise Review

Country wise, it is analyzed across India, China, Japan, South Korea, Australia, and Rest of Asia-Pacific. Japan accounted for the highest share of the market in 2016, followed by China. India is anticipated to witness the highest growth rate during the forecast period. In addition, this region is expected to emerge as the area with maximum growth potential due to the focus of key players in the emerging economies and improvement in the healthcare infrastructure.

Australia IVD Market ($Million), 2017-2023

Australia IVD Market ($Million), 2017-2023

Get more information on this report : Request Sample Pages

Increase in Prevalence of Non-communicable and Communicable Diseases

According to WHO, number of deaths due to non-communicable diseases (NCDs) is estimated to increase from 36 million deaths in 2010 to 44 million deaths in 2020; out of which the highest prevalence of NCDs is accounted in Western Pacific (12.3 million deaths) and South-East-Asia (10.4 million deaths) regions. According to OECD, Tuberculosis is the leading cause of death from infectious disease in the Asia-Pacific region. In 2014, OECD reported that four out of five countries in world; with the highest number of incident cases of tuberculosis, were in the Asia-Pacific region.

Increase in Geriatric Population

Geriatric population in Asia-Pacific has increased significantly and is vulnerable to various communicable and non-communicable diseases. According to the U.S. Census Bureau report “An Aging World: 2015” currently 7.9% of Asia population comprises of population aged 65 and over and this percentage is predicted to increase nearly 12.1% by 2030 and is anticipated to further increase to nearly 18.8% by 2050. Currently, Asia leads the world in speed of aging and size of older population and continue to lead during the forecast period. Therefore, the escalation in rate of the geriatric population is expected to raise the demand for diagnosis, thereby driving the IVD market.

Increasing Government Expenditures on Healthcare

There is a widespread awareness about spread of disease in Asia-Pacific countries and its impacts on the health. Hence, the government of all the regions have increased their healthcare expenditures for reducing the disease rate in the countries. According to the IMF World Economic Outlook database projections, the GDP of Asia is anticipated to increase from 5.3% in 2016 to 5.4% in 2018. Whereas, it also estimated that GDP of Pacific Island countries and other small states increased from 3.4% in 2016 to 3.8% in 2018. According to the WHO, the Japans’ government healthcare expenditure has increased from 20.12% in 2013 to 20.28% in 2014. The increase in Asia-Pacific economic conditions are expected to increase government funding in healthcare sector, which in turn contributes to the increase in the IVD market growth.

Major companies operating in this market adopted product launch as their key development strategy. Companies profiled in this market include, Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

Key Benefits:

  • The study provides in-depth analysis of the Asia-Pacific IVD market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis of the industry is provided for the period of 2016‐2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by technology and application helps understand various trends and prevailing opportunities in the market.
  • Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies.
  • The key market players are profiled and their strategies are analyzed to predict the competitive outlook of the market.

Asia-Pacific IVD Market Key Segments:

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Techniques

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassays (CLIAS)
      • Fluorescence Immunoassays (FIAS)
      • Colorimetric Immunoassays (CIS)
    • Rapid Tests
    • Enzyme-Linked Immunospot Assays (ELISPOT)
    • Radioimmunoassay
    • Western Blot
  • Blood Testing
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA Diagnostics
    • Microarrays
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Renal Profile
    • Electrolyte Panel
    • Specialty Chemicals
  • Other IVD Techniques

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Other Indications

By End Users

  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Point of Care Testing
  • Others

By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
 

Chapter: 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTER’S FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

Chapter: 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

Chapter: 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

Chapter: 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

Chapter: 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

Chapter: 8 ASIA-PACIFIC IVD MARKET

8.1 Key market trends
8.2 Key growth factors and opportunities
8.3 Market size and forecast
8.4 India

8.4.1 Market size and forecast

8.5 China

8.5.1 Market size and forecast

8.6 Japan

8.4.6.1 Market size and forecast

8.7 Australia

8.7.1 Market size and forecast

8.8 South Korea

8.8.1 Market size and forecast

8.9 Rest of Asia-Pacific

8.9.1 Market size and forecast

Chapter: 9 COMPANY PROFILES

9.1 THERMO FISHER SCIENTIFIC INC.

9.1.1 Company overview
9.1.2 Business performance
9.1.3 Key strategies and development

9.2 ALERE INC.

9.2.1 Company overview
9.2.2 Business performance
9.2.3 Key strategies and developments

9.3 BIOMERIEUX

9.3.1 Company overview
9.3.2 Business performance
9.3.3 Key strategies and developments

9.4 DANAHER CORPORATION

9.4.1 Company overview
9.4.2 Business performance
9.4.3 Key strategies and development

9.5 F. HOFFMANN-LA ROCHE AG

9.5.1 Company overview
9.5.2 Business performance
9.5.3 Key strategies and developments

9.6 BECTON DICKINSON AND COMPANY

9.6.1 Company overview
9.6.2 Business performance
9.6.3 Key strategies and development

9.7 BIO-RAD LABORATORIES

9.7.1 Company overview
9.7.2 Business performance
9.7.3 Key strategies and developments

9.8 BAYER AG

9.8.1 Company overview
9.8.2 Business performance
9.8.3 Key strategies and development

9.9 SYSMEX CORPORATION

9.9.1 Company overview
9.9.2 Business performance
9.9.3 Key strategies and developments

9.10 JOHNSON & JOHNSON

9.10.1 Company overview
9.10.2 Business performance
9.10.3 Key strategies and development

Table of Contents

TABLE 1 INCIDENCE OF DISEASES
TABLE 2 ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 ASIA-PACIFIC IVD REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 4 ASIA-PACIFIC IVD INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 5 ASIA-PACIFIC IVD SOFTWARE & SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 6 ASIA-PACIFIC IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 ASIA-PACIFIC IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 ASIA-PACIFIC IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY COUNTRY,2016-2023 ($MILLION)
TABLE 9 ASIA-PACIFIC IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 ASIA-PACIFIC IVD BLOOD TESTING TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11 ASIA-PACIFIC IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 ASIA-PACIFIC IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13 ASIA-PACIFIC IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 14 ASIA-PACIFIC IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15 ASIA-PACIFIC OTHER IVD TECHNIQUES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 16 ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 ASIA-PACIFIC IVD INFECTIOUS DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18 ASIA-PACIFIC IVD CANCER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19 ASIA-PACIFIC IVD CARDIAC DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20 ASIA-PACIFIC IVD IMMUNE SYSTEM DISORDER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 21 ASIA-PACIFIC IVD NEPHROLOGICAL DISEASES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 22 ASIA-PACIFIC IVD GASTROINTESTINAL DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23 ASIA-PACIFIC IVD OTHER INDICATION MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24 ASIA-PACIFIC IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 ASIA-PACIFIC IVD STANDALONE LABORATORIES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26 ASIA-PACIFIC IVD HOSPITALS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27 ASIA-PACIFIC IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28 ASIA-PACIFIC IVD POINT OF CARE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29 ASIA-PACIFIC IVD OTHER END-USER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30 ASIA-PACIFIC IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31 ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32 ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 33 ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34 ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 35 INDIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 36 INDIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 37 INDIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38 INDIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 39 CHINA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 40 CHINA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 41 CHINA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 42 CHINA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 43 JAPAN IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 44 JAPAN IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 45 JAPAN IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46 JAPAN IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 47 CATEGORIZATION OF IVD DEVICES
TABLE 48 AUSTRALIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 49 AUSTRALIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 50 AUSTRALIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 51 AUSTRALIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 52 SOUTH KOREA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53 SOUTH KOREA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 54 SOUTH KOREA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 55 SOUTH KOREA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 56 REST OF ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 57 REST OF ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 58 REST OF ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 59 REST OF ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 60 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 61 ALERE INC. COMPANY SNAPSHOT
TABLE 62 BIOMERIEUX COMPANY SNAPSHOT
TABLE 63 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 64 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 65 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 66 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 67 BAYER AG COMPANY SNAPSHOT
TABLE 68 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 69 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 ASIA-PACIFIC CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 ASIA-PACIFIC FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 ASIA-PACIFIC COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 ASIA-PACIFIC RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 ASIA-PACIFIC ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 ASIA-PACIFIC RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 ASIA-PACIFIC WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 ASIA-PACIFIC POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 ASIA-PACIFIC HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 ASIA-PACIFIC DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 ASIA-PACIFIC MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 ASIA-PACIFIC OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 ASIA-PACIFIC BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 ASIA-PACIFIC LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 ASIA-PACIFIC RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 ASIA-PACIFIC LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 ASIA-PACIFIC THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 ASIA-PACIFIC ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 ASIA-PACIFIC SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)

 

In vitro diagnostics (IVD) are diagnostic tools used alone or in combination to examine blood, urine, stool, tissues, and other body fluids of human body for detection of diseases, conditions, and infections in in vitro conditions. Different IVD products are used for this procedure such as reagents, instruments, and software & services. The reagents accounted for the highest market share in 2016 and is expected to dominate the market during the forecast period owing to accessibility of wide range of reagents that are cost efficient, reliable, and effective for fast diagnosis of diseases and disorders.


Japan accounted for the highest share owing to improving healthcare infrastructure due to increase in government expenditure in healthcare sector. According to the WHO, the Japanese government healthcare expenditure has increased from 20.12% in 2013 to 20.28% in 2014. India accounted for the highest market potential owing to rise in prevalence of communicable and non-communicable diseases such as tuberculosis, diabetes, cancer, and others. In addition, government initiatives for the improvement of healthcare sector, and rise in focus of leading manufacturers to expand their geographical presence in the emerging Indian economy are expected to gain high growth opportunities in the market.


Major companies involved in the Asia-Pacific IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Asia Pacific IVD Market- Opportunity Analysis and Industry Forecast, 2017-2023

  • Data Pack
  • $2151
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $3051
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $3665
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $5110
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo